Evolent Health (EVH) Tops Q4 EPS by 3c

Evolent Health (NYSE: EVH) reported Q4 EPS of $0.08, $0.03 better than the analyst estimate of $0.05. Revenue for the quarter came in at $468.72 million versus the consensus estimate of $469.09 million.

For earnings history and earnings-related data on Evolent Health (EVH) click here.

You May Also Be Interested In

• Jersey Mike's Subs files for IPO on NYSE under ticker JMKE
• DOJ Probing Alleged Insider Trades That Stung Susquehanna - Bloomberg
• Moderna (MRNA) call put ratio 5 calls to 1 put with a focus on July 10 weekly 80 and 85 calls as share price up 6.5%